Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$4.35 - $6.88 $189,999 - $300,504
-43,678 Reduced 75.31%
14,322 $92,000
Q3 2023

Nov 14, 2023

BUY
$4.52 - $8.9 $75,936 - $149,520
16,800 Added 40.78%
58,000 $262,000
Q2 2023

Aug 11, 2023

SELL
$4.79 - $8.3 $207,886 - $360,220
-43,400 Reduced 51.3%
41,200 $244,000
Q1 2023

May 12, 2023

BUY
$5.3 - $10.93 $306,340 - $631,754
57,800 Added 215.67%
84,600 $448,000
Q4 2022

Feb 13, 2023

BUY
$4.1 - $8.94 $109,879 - $239,592
26,800 New
26,800 $143,000
Q2 2022

Aug 12, 2022

BUY
$6.92 - $15.97 $97,572 - $225,177
14,100 New
14,100 $154,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.